Trial
NCT01570348
Crohn's Allogeneic Transplant Study
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI); National Institutes of Health (NIH)
Condition
Crohn Disease
Intervention
Allogeneic Bone Marrow Transplantation
Why stopped
Annual accrual goal not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-17